Presumptive positive with the Cepheid Xpert Xpress SARS-CoV-2 assay due to N mutations in the Delta variantDelta 변이체의 N 돌연변이로 인한 Cepheid Xpert Xpress SARS-CoV-2 분석에서 추정 양성Article Published on 2022-07-012022-09-11 Journal: Diagnostic microbiology and infectious disease [Category] COVID19(2023년), SARS, 변종, 치료기술, 치료제, [키워드] 2019-nCoV authorization C29200T C29203T Cepheid Cepheid Xpert® Xpress SARS-CoV-2 assay Chain Reaction Delta delta variant Delta variants drug Emergency Emergency use authorization false False negative FDA food indicated Mutation N gene N mutation PCR assay platform Point mutation point mutations polymerase chain polymerase chain reaction positive presumptive positive. real time PCR real-time RT-PCR reported reverse transcription RT-PCR RT-PCR assay SARS-CoV-2 SARS-CoV-2 detection the United State United States United States Food and Drug Administration US CDC variants Whole genome sequencing [DOI] 10.1016/j.diagmicrobio.2022.115699 PMC 바로가기 [Article Type] Article
Coexistence of SARS-CoV-2 and cerebrovascular diseases: does COVID-19 positivity trigger cerebrovascular pathologies?Article Published on 2022-06-302023-07-09 Journal: Journal of infection in developing countries [Category] COVID19(2023년), [키워드] 2019-nCoV Intracerebral hemorrhage ischemic cerebrovascular diseases pharmacological treatment protocols. SARS-CoV-2 [DOI] 10.3855/jidc.15800
Analysis of 4 cases of children with false-positive results of novel coronavirus-specific antibody신종 코로나바이러스 특이항체 위양성 아동 4건 분석Article Published on 2022-06-282022-09-11 Journal: BMC Pediatrics [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] 2019 2019-nCoV 2019-nCoV infection adopted antibodies antibody Antibody detection Capital children Children's Hospital clinical experience clinical manifestations clinical records collected colloidal gold Colloidal gold antibody detection method Coronavirus infection COVID-19 COVID-19 diagnosis detect Diagnosis epidemiological history examination process examined Factor false False-positive false-positive result gold IgG IgG antibodies IgG antibody IgM IgM/IgG interfere mass mass spectrometry nCoV novel Novel coronavirus Novel coronavirus infection nucleic acid nucleic acid test nucleic acid tests outpatient clinic Patient pediatrics plasma Protein serum Serum protein single antibody specific IgM test results tested virus nucleic acid was used Whole blood [DOI] 10.1186/s12887-022-03425-9 PMC 바로가기 [Article Type] Article
COVID-19 Australia: Epidemiology Report 61 Reporting period ending 8 May 2022Article Published on 2022-06-152023-07-09 Journal: Communicable diseases intelligence (2018) [Category] COVID19(2023년), [키워드] 2019-nCoV acute respiratory disease Australia Coronavirus disease 2019 COVID-19 Epidemiology Novel coronavirus SARS-CoV-2 [DOI] 10.33321/cdi.2022.46.37
Egg-Derived Anti-SARS-CoV-2 Immunoglobulin Y (IgY) With Broad Variant Activity as Intranasal Prophylaxis Against COVID-19COVID-19에 대한 비강내 예방으로서 광범위한 변이 활성을 갖는 계란 유래 항-SARS-CoV-2 면역글로불린 Y(IgY)Clinical Trial Published on 2022-06-012022-09-11 Journal: Frontiers in Immunology [Category] COVID19(2023년), MERS, SARS, 변종, 임상, 진단, [키워드] 2019 novel coronavirus 2019-nCoV activity Administered Against Alpha anti-SARS-CoV-2 Antiviral approval approvals B.1.1.529 B.1.1.7 B.1.351 B.1.617.2 Beta binding capture chicken immunoglobulin clinical clinical trial clinical trial body Clinical use contagiousness Convalescent patients COVID-19 cross-reactivity Delta demonstrated develop Diseases distribution double-blind effective Emergency use authorization enzyme enzyme-linked immunosorbent enzyme-linked immunosorbent assay Evidence evidence of greater healthy human tissue human tissues IgY Immunity immunized Immunoglobulin immunoglobulin Y index Infectious diseases intranasal intranasally multiple dose multiple doses nasal drop nasal drops nasal mucosa neutralization titer no evidence of Novel coronavirus omicron Phase 1 phase 1 study Placebo placebo-controlled Prevalence Prophylaxis raised Randomized RATs RBD Receptor-binding domain reduce reduced risk Safe safety profile SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 spike protein SARS-CoV-2 strain SARS-CoV-2 variant SARS-CoV-2 variants SARS-CoV-2 viral sensitivity sera Spike protein the receptor-binding domain the SARS-CoV-2 Tolerability Transmission Trial Vaccine Vaccine hesitancy variants variants of concern variety Viral virus [DOI] 10.3389/fimmu.2022.899617 PMC 바로가기 [Article Type] Clinical Trial
COVID-19 Australia: Epidemiology Report 60: Reporting period ending 10 April 2022Article Published on 2022-05-112023-07-09 Journal: Communicable diseases intelligence (2018) [Category] COVID19(2023년), [키워드] 2019-nCoV acute respiratory disease Australia Coronavirus disease 2019 COVID-19 Epidemiology Novel coronavirus SARS-CoV-2 [DOI] 10.33321/cdi.2022.46.33
In Silico Prediction of New Mutations That Can Improve the Binding Abilities Between 2019-nCoV Coronavirus and Human ACE22019-nCoV 코로나바이러스와 인간 ACE2 간의 결합 능력을 향상시킬 수 있는 새로운 돌연변이의 실리코 예측Article Published on 2022-05-012022-09-11 Journal: IEEE/ACM transactions on computational biology and [Category] COVID19(2023년), SARS, 변종, 유전자 메커니즘, 치료기술, [키워드] 2019-nCoV Ability ACE2 Amino acid Analysis binding binding ability binding free energies binding free energy calculate Can change conducted coronavirus coronavirus disease Coronavirus disease 2019 coronavirus spike protein COVID-19 drug drug and vaccine development dynamic ENhance Epidemic Health help Human human ACE2 IMPROVE Interaction international public health mechanism molecular dynamic simulations mutant Mutation mutations nCoV New pathogenic prediction Protein Research selected Simulation Spike protein susceptible The 2019-nCoV Vaccine development virus transmission was obtained [DOI] 10.1109/TCBB.2021.3058265 PMC 바로가기 [Article Type] Article
Comparison of COVID-19 laboratory diagnosis by commercial kits: Effectivity of RT-PCR to the RT-LAMP상용 키트에 의한 COVID-19 실험실 진단의 비교: RT-LAMP에 대한 RT-PCR의 유효성Article Published on 2022-05-012022-09-11 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] 2019-nCoV acute respiratory syndrome acute respiratory syndrome coronavirus approach caused Chain Reaction contribute coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 Diagnosis diagnostic diagnostic test diagnostic testing Effect Effectiveness effort evaluate faster gold gold standard IMPROVE individual isothermal amplification Laboratory LAMP LAMP-PCR Loop-mediated isothermal amplification MONITOR Nasopharyngeal swab nasopharyngeal swabs Novel coronavirus pandemic Patient PCR polymerase chain reaction portion q-RT-PCR q-RT-PCR. Qiagen quantification quantitative reverse transcription-polymerase chain reaction Randomly Rotor-Gene Q RT-LAMP RT-PCR RT-PCR kit SARS-CoV-2 SARS-CoV-2 test sequence severe acute respiratory syndrome Coronavirus technology tested the SARS-CoV-2 Transcription was tested [DOI] 10.1002/jmv.27559 PMC 바로가기 [Article Type] Article
Performance evaluation of novel fluorescent-based lateral flow immunoassay (LFIA) for rapid detection and quantification of total anti-SARS-CoV-2 S-RBD binding antibodies in infected individuals감염된 개인에서 총 항-SARS-CoV-2 S-RBD 결합 항체의 신속한 검출 및 정량화를 위한 새로운 형광 기반 측면 유동 면역분석(LFIA)의 성능 평가Article Published on 2022-05-012022-09-11 Journal: International Journal of Infectious Diseases [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] 2019-nCoV anti-SARS-CoV-2 Antibody Units automated binding binding antibody binding antibody unit bioMérieux can be used correlation COVID-19 detect domain evaluate Flow Fluorescence Fluorescence immunoassay France Genscript infected individual Infection Laboratory Lateral lateral flow assay lateral flow immunoassay LFIA majority Model moderate Neutralizing antibody response PCR performance plasma positive individual positive individuals quantification Quantitative quantitative measurement RT-PCR S-RBD SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-CoV-2 spike protein sensitivity Sensitivity and specificity serology specificity Spike protein surrogate sVNT tested USA vaccination virus-neutralizing [DOI] 10.1016/j.ijid.2022.02.052 PMC 바로가기 [Article Type] Article
Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised Patients면역 저하 환자의 COVID-19 mRNA 백신에 의한 우려 변종에 대한 체액 반응Article Published on 2022-05-012022-09-11 Journal: JAMA Oncology [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] 2019-nCoV Against age All participant All participants Alpha anti-spike antibody Antibody titer Antibody titers association Autoimmune disease Autoimmune diseases best Beta Beta variant binding BNT162b2 BNT162b2 vaccine BNT162b2 vaccines Cancer cancers circulating concern conducted COVID-19 decrease Delta delta variant Delta variants dose Effectiveness elicited enrolled female Gamma greater healthy control healthy controls hematologic Humoral response humoral responses IgG Immunocompromised patient Immunocompromised patients median Messenger RNA Moderna mRNA mRNA vaccine mRNA-1273 NAb NAb responses NAbs nCoV neutralizing antibody neutralizing antibody titers outcome participant Participants Patient patient population performed persistence Pfizer-BioNTech Primary outcome proportion proportions response response to vaccination responses against SARS-CoV-2 SARS-CoV-2 variants secondary outcome solid cancers solid organ solid organ transplant solid organ transplants study group the healthy the patient the SARS-CoV-2 Treatment underlying disease university vaccination vaccination schedule Vaccine Vaccines variant variants variants of concern VoC VOCs were measured [DOI] 10.1001/jamaoncol.2022.0446 PMC 바로가기 [Article Type] Article